Global mRNA Vaccines & Therapeutics Market by Player, Region, Type, Application and Sales Channel

  • This report studies the mRNA Vaccines & Therapeutics market, covering market size for segment by type (Standardization of Cancer Treatment MRNA Vaccine, Individualized Cancer Treatment MRNA Vaccine, etc.), by application (Infectious Disease, Cancer, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).


    This report provides detailed historical analysis of global market for mRNA Vaccines & Therapeutics from 2017-2022, and provides extensive market forecasts from 2023-2031 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the mRNA Vaccines & Therapeutics market.


    Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.


    This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.


    The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.


    Leading players of mRNA Vaccines & Therapeutics including:

    Moderna Therapeutics

    CureVac

    Translate Bio

    BioNTech

    Sangamo Therapeutics

    Argos Therapeutics

    In-Cell-Art

    eTheRNA

    Ethris

    Tiba Biotechnology


    Market split by Type, can be divided into:

    Standardization of Cancer Treatment MRNA Vaccine

    Individualized Cancer Treatment MRNA Vaccine

    Infectious Disease Treatment MRNA Vaccine

    Infection Prevention MRNA Vaccine


    Market split by Application, can be divided into:

    Infectious Disease

    Cancer

    Other


    Market split by Sales Channel, can be divided into:

    Direct Channel

    Distribution Channel


    Market segment by Region/Country including:

    North America (United States, Canada and Mexico)

    Europe (Germany, UK, France, Italy, Russia and Spain etc.)

    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

    South America (Brazil, Argentina and Colombia etc.)

    Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)


    If you have any special requirements, please let us know and we can provide you the customized report as you want.


     

  • With tables and figures helping analyze worldwide Global mRNA Vaccines & Therapeutics market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Chapter 1 mRNA Vaccines & Therapeutics Market Overview

    1.1 mRNA Vaccines & Therapeutics Definition

    1.2 Global mRNA Vaccines & Therapeutics Market Size Status and Outlook (2017-2031)

    1.3 Global mRNA Vaccines & Therapeutics Market Size Comparison by Region (2017-2031)

    1.4 Global mRNA Vaccines & Therapeutics Market Size Comparison by Type (2017-2031)

    1.5 Global mRNA Vaccines & Therapeutics Market Size Comparison by Application (2017-2031)

    1.6 Global mRNA Vaccines & Therapeutics Market Size Comparison by Sales Channel (2017-2031)

    1.7 mRNA Vaccines & Therapeutics Market Dynamics
    1.7.1 Market Drivers/Opportunities
    1.7.2 Market Challenges/Risks
    1.7.3 Market News (Mergers/Acquisitions/Expansion)
    1.7.4 COVID-19 Impacts
    1.7.5 Russia-Ukraine War Impacts
    Chapter 2 mRNA Vaccines & Therapeutics Market Segment Analysis by Player

    2.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Player (2020-2022)

    2.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Player (2020-2022)

    2.3 Global mRNA Vaccines & Therapeutics Average Price by Player (2020-2022)

    2.4 Players Competition Situation & Trends

    2.5 Conclusion of Segment by Player

    Chapter 3 mRNA Vaccines & Therapeutics Market Segment Analysis by Type

    3.1 Global mRNA Vaccines & Therapeutics Market by Type

    3.1.1 Standardization of Cancer Treatment MRNA Vaccine
    3.1.2 Individualized Cancer Treatment MRNA Vaccine
    3.1.3 Infectious Disease Treatment MRNA Vaccine
    3.1.4 Infection Prevention MRNA Vaccine

    3.2 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2017-2022)

    3.3 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2017-2022)

    3.4 Global mRNA Vaccines & Therapeutics Average Price by Type (2017-2022)

    3.5 Leading Players of mRNA Vaccines & Therapeutics by Type in 2022

    3.6 Conclusion of Segment by Type

    Chapter 4 mRNA Vaccines & Therapeutics Market Segment Analysis by Application

    4.1 Global mRNA Vaccines & Therapeutics Market by Application

    4.1.1 Infectious Disease
    4.1.2 Cancer
    4.1.3 Other

    4.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Application (2017-2022)

    4.3 Leading Consumers of mRNA Vaccines & Therapeutics by Application in 2022

    4.4 Conclusion of Segment by Application

    Chapter 5 mRNA Vaccines & Therapeutics Market Segment Analysis by Sales Channel

    5.1 Global mRNA Vaccines & Therapeutics Market by Sales Channel

    5.1.1 Direct Channel
    5.1.2 Distribution Channel

    5.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Sales Channel (2017-2022)

    5.3 Leading Distributors/Dealers of mRNA Vaccines & Therapeutics by Sales Channel in 2022

    5.4 Conclusion of Segment by Sales Channel

    Chapter 6 mRNA Vaccines & Therapeutics Market Segment Analysis by Region

    6.1 Global mRNA Vaccines & Therapeutics Market Size and CAGR by Region (2017-2031)

    6.2 Global mRNA Vaccines & Therapeutics Sales and Market Share by Region (2017-2022)

    6.3 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Region (2017-2022)

    6.4 North America

    6.4.1 North America Market by Country
    6.4.2 North America mRNA Vaccines & Therapeutics Market Share by Type
    6.4.3 North America mRNA Vaccines & Therapeutics Market Share by Application
    6.4.4 United States
    6.4.5 Canada
    6.4.6 Mexico

    6.5 Europe

    6.5.1 Europe Market by Country
    6.5.2 Europe mRNA Vaccines & Therapeutics Market Share by Type
    6.5.3 Europe mRNA Vaccines & Therapeutics Market Share by Application
    6.5.4 Germany
    6.5.5 UK
    6.5.6 France
    6.5.7 Italy
    6.5.8 Russia
    6.5.9 Spain

    6.6 Asia-Pacific

    6.6.1 Asia-Pacific Market by Country
    6.6.2 Asia-Pacific mRNA Vaccines & Therapeutics Market Share by Type
    6.6.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Share by Application
    6.6.4 China
    6.6.5 Japan
    6.6.6 Korea
    6.6.7 India
    6.6.8 Southeast Asia
    6.6.9 Australia
    6.7 South America
    6.7.1 South America Market by Country
    6.7.2 South America mRNA Vaccines & Therapeutics Market Share by Type
    6.7.3 South America mRNA Vaccines & Therapeutics Market Share by Application
    6.7.4 Brazil
    6.7.5 Argentina
    6.7.6 Colombia
    6.8 Middle East & Africa
    6.8.1 Middle East & Africa Market by Country
    6.8.2 Middle East & Africa mRNA Vaccines & Therapeutics Market Share by Type
    6.8.3 Middle East & Africa mRNA Vaccines & Therapeutics Market Share by Application
    6.8.4 UAE
    6.8.5 Saudi Arabia
    6.8.6 South Africa
    6.9 Conclusion of Segment by Region
    Chapter 7 Profile of Leading mRNA Vaccines & Therapeutics Players

    7.1 Moderna Therapeutics

    7.1.1 Company Snapshot
    7.1.2 Product/Service Offered
    7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

    7.2 CureVac

    7.3 Translate Bio

    7.4 BioNTech

    7.5 Sangamo Therapeutics

    7.6 Argos Therapeutics

    7.7 In-Cell-Art
    7.8 eTheRNA
    7.9 Ethris

    7.10 Tiba Biotechnology

    Chapter 8 Upstream and Downstream Analysis of mRNA Vaccines & Therapeutics

    8.1 Industrial Chain of mRNA Vaccines & Therapeutics

    8.2 Upstream of mRNA Vaccines & Therapeutics

    8.3 Downstream of mRNA Vaccines & Therapeutics

    Chapter 9 Development Trend of mRNA Vaccines & Therapeutics (2023-2031)

    9.1 Global mRNA Vaccines & Therapeutics Market Size (Sales and Revenue) Forecast (2023-2031)

    9.2 Global mRNA Vaccines & Therapeutics Market Size and CAGR Forecast by Region (2023-2031)

    9.3 Global mRNA Vaccines & Therapeutics Market Size and CAGR Forecast by Type (2023-2031)

    9.4 Global mRNA Vaccines & Therapeutics Market Size and CAGR Forecast by Application (2023-2031)

    9.5 Global mRNA Vaccines & Therapeutics Market Size and CAGR Forecast by Sales Channel (2023-2031)

    Chapter 10 Appendix

    10.1 Research Methodology

    10.2 Data Sources

    10.3 Disclaimer

    10.4 Analysts Certification

     

  • The Global mRNA Vaccines & Therapeutics Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
      By Regions:
        By Type:
          By Application:
          Frequently asked questions(FAQ's):
          Why are some of the most well-known companies left out of the Global mRNA Vaccines & Therapeutics Market study?

          The Global mRNA Vaccines & Therapeutics study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.

          What are the major applications of the Global mRNA Vaccines & Therapeutics Market?

          Depending upon the type of applications, the Global mRNA Vaccines & Therapeutics Market has been segmented into and other applications.

          What is the market value of the Global mRNA Vaccines & Therapeutics Industry?

          In 2023, the Global mRNA Vaccines & Therapeutics Market share exceeded USD xx million. Between 2024 and 2029, it will grow at a CAGR of yy%.

          What challenges does the Global mRNA Vaccines & Therapeutics Market face in the future?

          The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Global mRNA Vaccines & Therapeutics Market across the extensive corporate landscape.

          What makes the latest Global mRNA Vaccines & Therapeutics Market study unique?

          The latest version of the Global mRNA Vaccines & Therapeutics Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.

          Our Clients